Hepatocellular Carcinoma with Bile Duct Tumor Thrombi (Icteric Hepatoma)– A 19 Year Experience from a Tertiary Care Centre

Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 12

Abstract

Introduction/Objective: Hepatocellular carcinoma presenting with obstructive jaundice due to bile duct tumor thrombi is a rare entity, with a reported incidence worldwide of about 1 to 12 %. The objective of this study is to analyse the clinicopathological and post-surgical outcomes in patients who had hepatocellular carcinoma with bile duct tumor thrombi. Materials and Methods: 42 cases of pathologically proven Hepatocellular carcinoma with bile duct tumor thrombi in non-cirrhotic liver, who underwent hepatectomies at Institute of Surgical Gastroenterology and Liver Transplant, Government Stanley Medical College and hospital, between January 1997 and September 2016 were analysed retrospectively. Clinicopathological, biochemical, radiological, operative variables and post-operative morbidity and mortality were analysed. Results: Pre-operative AFP were elevated in 28 patients (> 400 ng/ml). Right hepatectomy with thrombectomy and T tube drainage, extended right hepatectomy with bile duct excision, left hepatectomy, extended left hepatectomy with bile duct excision, left lateral segmentectomy were done in 17,11,10,2 and 2 patients respectively. 14 patients had significant post-operative morbidity while mortality was seen in three patients. Median survival was about 27.2 months. Tumor recurrence was observed in 28 of 42 cases (66.67%) with a median time to recurrence of about 10.3 months. Conclusion: Bile duct tumor thrombi does not preclude hepatic resection and these patients who are otherwise fit to undergo hepatectomy are offered surgery as the first line treatment.

Authors and Affiliations

Dr R. Kamalakannan

Keywords

Related Articles

A Prospective Evaluation of Hemoptysis Cases in a Tertiary Referral Hospital

Background: Haemoptysis is an alarming symptom, and the management depends upon the aetiology. The etiology of hemoptysis in various studies is based on the geographic location, the patient population studied, the diagno...

Investigating the use of biothesiometer for Detecting the Severity of Diabetic Neuropathy in Diabetic Type- II Patients

Diabetes Mellitus is a double edged sword which can result in both microvascular and macrovascular complications, of which Diabetic Neuropathy has been reportedly under diagnosedor misdiagnosed. With changing technologie...

Prevalence of Hyperuricemia and Relation of Serum Uric Acid with Cardiometabolic Risk Factors

Cardiometabolic diseases like metabolic syndrome (Mets), cardiovascular disease (CVD) and type 2 diabetes mellitus have several risk factors in common. Several biochemical markers are in current use as laboratory diagnos...

Comparison of Epidural Fentanyl and Buprenorphine as Adjuvants to Bupivacaine in Lower Abdominal Surgeries: A Randomized Clinical Study

Background: Epidural neuraxial opioids when added to local anaesthetics improves the onset and duration of analgesia. The present study was conducted to evaluate the safety and efficacy of epidural buprenorphine and fent...

Ebola: The Deadly Viral Infection Should Hindustan Be Prepared?

Ebola viruses are one of the most deadliest group of viruses known to mankind. With case fatality rate of more than 90% it’s among 30 viruses which causes viral hemorrhagic fever syndrome. Endemic among sub African regio...

Download PDF file
  • EP ID EP519937
  • DOI -
  • Views 57
  • Downloads 0

How To Cite

Dr R. Kamalakannan (2017). Hepatocellular Carcinoma with Bile Duct Tumor Thrombi (Icteric Hepatoma)– A 19 Year Experience from a Tertiary Care Centre. Journal of Medical Science And clinical Research, 5(12), 31741-31748. https://europub.co.uk/articles/-A-519937